
On March 28, 2026, the U.S. Food and Drug Administration (FDA) announced a major upgrade to its Voluntary Cosmetic Registration Program (VCRP), introducing new features such as address verification, structured ingredient reporting, and annual compliance declarations. The move signals potential future mandatory registration, with current registration rates for Chinese exporters at just 11.7%, significantly lower than South Korea (89%) and Mexico (76%). This development is critical for cosmetic manufacturers, exporters, and supply chain stakeholders as non-registered products may face heightened scrutiny during FDA inspections, impacting market access and retailer partnerships.
The FDA's upgraded VCRP now requires: 1) validation of business addresses, 2) structured data submission for product ingredients, and 3) annual compliance statements. While participation remains voluntary, the agency explicitly warned that unregistered products will be prioritized for field examinations and sampling, potentially delaying market entry. The announcement did not specify an implementation timeline for mandatory registration but emphasized enhanced monitoring of non-compliant entities.
Brands shipping cosmetics to the U.S. must now weigh registration costs against potential border inspection delays. Analysis shows FDA examination rates for unregistered products increased 300% in 2025 test markets.
Structured data requirements will force upstream suppliers to standardize documentation, particularly for botanicals and synthetic compounds where nomenclature varies.
Major chains may require VCRP registration proof from vendors following Walmart's 2025 pilot requiring documentation for private-label cosmetics.
Current data suggests FDA focuses inspections on mass-market color cosmetics and skincare, representing 82% of 2025 examinations.
Reconcile supplier specifications with FDA's new structured format, particularly for preservatives and UV filters with complex INCI names.
CVS and Target have begun requesting VCRP status in vendor questionnaires - expect this to become standard practice by Q3 2026.
Annual declaration requirements suggest ongoing administrative burden - consider dedicated regulatory staff for companies with 50+ SKUs.
From an industry standpoint, this appears to be a transitional measure toward mandatory registration. The structured data component suggests FDA is building infrastructure for eventual electronic submission mandates. More immediately concerning is the 11.7% Chinese registration rate - likely reflecting misunderstanding of "voluntary" as optional rather than de facto market requirement. Brands should treat VCRP as essential customs documentation, not an optional program.
While not yet legislatively mandatory, the FDA's VCRP upgrades create practical necessity for registration. The combination of retailer adoption and heightened inspection targeting means non-participation now carries measurable business risk. Companies should view this as analogous to EU CPNP registration - technically voluntary but commercially essential.
1. FDA Federal Register Notice (March 28, 2026)
2. U.S. Customs and Border Protection Cosmetic Examination Data (2025)
3. National Cosmetic Industry Association Compliance Bulletin (March 2026)
*Ongoing: Monitoring Congressional hearings regarding potential Cosmetic Modernization Act amendments
Related Intelligence